March 04, 2015 2:38 PM ET

Healthcare Equipment and Supplies

Company Overview of Nanomix, Inc.

Company Overview

Nanomix, Inc., a nanotechnology company, provides analytical detection devices for rapid point of care (POC) diagnostics. The company focuses on the development of mobile diagnostic tests to enable earlier and accurate testing in hospital and pre-hospital settings. It offers Nanomix System that includes a handheld reader, and an integrated and self-contained assay cartridge with a carbon nano structures biosensor for testing at the point of patient care; and Nanomix eLab, a POC testing solution for use in emergency departments and by pre-hospital first responders to speed data availability for faster diagnosis of acute myocardial infarction. The company’s Nanomix System is also used for loca...

5980 Horton Street

Suite 600

Emeryville, CA 94608

United States

Founded in 2000





Key Executives for Nanomix, Inc.

Chief Executive Officer and President
Age: 63
Founder and Executive Chairman
Age: 57
Co-Founder, Co-Chairperson of Scientific Advisory Board, Chief Scientific Officer and Director
Co-Founder, Co-Chairperson of Scientific Advisory Board and Board Advisor
Chief Financial Officer and Vice President of Finance
Compensation as of Fiscal Year 2014.

Nanomix, Inc. Key Developments

Nanomix, Inc. Appoints Tom Richards as Senior Advisor

Nanomix, Inc. announced the appointment of Dr. Tom Richards as a Senior Advisor. Dr. Richards brings a wealth of healthcare and financial executive experience to Nanomix as the company drives towards the commercial launch of its first product. Prior to joining Nanomix as Senior Advisor, Dr. Richards was President and CEO of TessArae. He has previously served as an academic physician on the clinical faculty of Stanford University and most recently as an Assistant Professor of Emergency Medicine at UCSF.

Nanomix, Inc. Appoints Brian Jung as Vice President of Finance and Chief Financial Officer

Nanomix, Inc. announced the appointment of Brian Jung as Vice President of Finance and Chief Financial Officer. Mr. Jung brings significant financial and executive experience to Nanmix, having served in CFO and executive roles for several healthcare and life science companies.

Nanomix Inc. Closes Private Financing for Approximately $12 Million

Nanomix Inc. announced that is has closed private financing for approximately $12 million. The financing, received from a strategic corporate partner and existing investors, will fund the completion of development, registration clinical trials, and commercial launch of the company's mobile diagnostic platform and initial assays.

Similar Private Companies By Industry

Company Name Region
ConMediSys, Inc. United States
Axenic Dental, Inc. United States
Summit Limb Technologies United States
Panoramic Corporation United States
PRIMUS Sterilizer Company, L.L.C. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Nanomix, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at